CALITHERA BIOSCIENCES INC (CALA) Financials
CALA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2022-12-31 | 28.7 million | 8.3 million |
2022-09-30 | 37.1 million | 10.7 million |
2022-06-30 | 45.6 million | 10.3 million |
2022-03-31 | 50.2 million | 53.4 million |
CALA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2022-12-31 | -8.6 million | 936000 |
2022-09-30 | -7.7 million | 939000 |
2022-06-30 | -11.4 million | 975000 |
2022-03-31 | -16.0 million | 1.2 million |
CALA Net Income
No data available :(
CALA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2022-12-31 | 25.5 million | - | 1.7 million |
2022-09-30 | 34.1 million | - | 2.0 million |
2022-06-30 | 41.8 million | - | 2.4 million |
2022-03-31 | 44.7 million | - | 2.7 million |
CALA Shares Outstanding
CALA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2022-12-31 | 23000 | 4.8 million | 2.6 million | - |
2022-09-30 | 110000 | 6.4 million | 3.1 million | - |
2022-06-30 | 110000 | 7.8 million | 3.6 million | - |
2022-03-31 | 110000 | 9.6 million | 4.3 million | - |
CALA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2022-12-31 | - | - |
2022-09-30 | - | - |
2022-06-30 | - | - |
2022-03-31 | - | - |
CALA
Price: $0.02
52 week price:
Earnings Per Share: -7.94 USD
P/E Ratio: -3.31
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 883600
Ebitda: -6.6 millionMarket Capitalization: 243625